Pharmacokinetics of plasma lopinavir and ritonavir in tuberculosis–HIV co-infected African adult patients also receiving rifabutin 150 or 300 mg three times per week
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Clinical Microbiology and Antimicrobials"
DOI: 10.1186/s12941-020-0345-6
Abstract: Background To evaluate the pharmacokinetic of plasma lopinavir (LPV) and ritonavir (RTV) when co-administered with three times weekly (TPW) rifabutin (RBT) at a dose of either 150 or 300 mg in African tuberculosis (TB) and HIV… read more here.
Keywords: three times; plasma lopinavir; 150 300; tuberculosis ... See more keywords